background image

Lupus Clinical Trials

Find clinical trials for Lupus. Search for Lupus clinical trials in different cities and states across the United States.

Filter
1

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1)

Recruiting
PHASE1

Sponsor:

Nkarta, Inc.

Location:

Little Rock AR, Atlanta GA, Worcester MA, New York NY

Code:

NCT06557265

Conditions

Lupus Nephritis

Glomerulonephritis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NKX019

Cyclophosphamide

Delivery of Enhance Fitness Trial

Recruiting

Sponsor:

University of Washington

Location:

Seattle WA

Code:

NCT05275348

Conditions

Arthritis

Rheumatoid Arthritis

Fibromyalgia

Gout

Osteoarthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tele-Enhance Fitness

In-person Enhance Fitness

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Recruiting
PHASE1

Sponsor:

Cullinan Therapeutics Inc.

Location:

Orlando FL, Webster TX

Code:

NCT06613360

Conditions

SLE

SLE (Systemic Lupus)

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

CLN-978

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Recruiting
PHASE2

Sponsor:

Novartis Pharmaceuticals

Location:

Anniston AL, Fullerton CA, La Palma CA, Winter Park FLshow 14 more

Code:

NCT06293365

Conditions

Sjögrens Disease

Systemic Lupus Erythematosus

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

VAY736 1ml PFS

VAY736 2 ml PFS

VAY736 2ml AI

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

Recruiting
PHASE2
PHASE3

Sponsor:

Biogen

Location:

Anniston AL, Birmingham AL, Phoenix AZ, La Jolla CAshow 51 more

Code:

NCT05531565

Conditions

Subacute Cutaneous Lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Litifilimab

Placebo

Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology

Recruiting

Sponsor:

Cedars-Sinai Medical Center

Location:

Beverly Hills CA

Code:

NCT03459274

Conditions

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Spondyloarthropathy

Vasculitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

VR-Biofeedback

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Recruiting
PHASE1

Sponsor:

Artiva Biotherapeutics, Inc.

Location:

Birmingham AL, San Diego CA

Code:

NCT06265220

Conditions

Lupus Nephritis - WHO Class III

Lupus Nephritis - WHO Class IV

Refractory Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AB-101

Cyclophosphamide

Fludarabine

Rituximab

Obinutuzumab

Descartes-08 for Patients With Systemic Lupus Erythematosus

Recruiting
PHASE2

Sponsor:

Cartesian Therapeutics

Location:

Oceanside CA

Code:

NCT06038474

Conditions

Systemic Lupus Erythematosus (SLE)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Descartes-08

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Recruiting
PHASE2

Sponsor:

Novartis Pharmaceuticals

Location:

Phoenix AZ, Hinsdale IL, Baltimore MD

Code:

NCT05268289

Conditions

Lupus Nephritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Iptacopan (part 1)

Iptacopan (part 2)

Placebo + standard of care

Iptacopan + placebo

A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus

Recruiting
PHASE2

Sponsor:

Galapagos NV

Location:

Tucson AZ, La Jolla CA, Rancho Mirage CA, Simi Valley CAshow 15 more

Code:

NCT05856448

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GLPG3667

Placebo

What are clinical trials for lupus?

What types of clinical trials are used for lupus?

Why participate in a clinical trial for lupus?

Who can participate in a clinical trial for lupus?

How to enroll in a lupus clinical trial